Skip to main content

RDHL · RedHill Biopharma Ltd. · Webcasts, Transcripts & Audio

Track RDHL — free
$0.50 +0.01 (+1.42%)
Market Cap
$3.04M
Shares
6.08M
Volume · Oct 6 57.88K Avg daily vol (3M) 1.79M

RedHill Biopharma Ltd. Webcasts

Earnings calls, investor updates, investor days and conferences for RedHill Biopharma Ltd. (RDHL), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
Earnings call
FY22 · Q1
2022-03-31
RedHill Biopharma Ltd. (RDHL) Q1 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
RedHill Biopharma Ltd. (RDHL) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-10-07
RedHill Biopharma Ltd. (RDHL) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-26
RedHill Biopharma Ltd. (RDHL) Q2 2021 Earnings Call Transcript
Revenue
$21.50M
▲ 2.9% YoY
Diluted EPS
$-60.00
Gross margin
50.7%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-27
RedHill Biopharma Ltd. (RDHL) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-18
RedHill Biopharma Ltd. (RDHL) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-12
RedHill Biopharma Ltd. (RDHL) Q3 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-13
RedHill Biopharma Ltd. (RDHL) Q2 2020 Earnings Call Transcript
Revenue
$20.90M
▲ 1237.1% YoY
Gross margin
32.1%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-03-26
RedHill Biopharma Ltd. (RDHL) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–9 of 9 webcasts
Key facts CIK 1553846 CUSIP 757468301 Visit website Investor relations